30 C
Jaipur
Saturday, October 31, 2020

Russia Approves 1st COVID-19 Vaccine, But People Are Questioning It

Must read

Amazon sale: Up to Rs 41,400 discount on gaming laptops from Asus, Acer, MSI, Lenovo and others

If you are planning to buy a gaming laptop, then it may be a good idea to check out the deals on Amazon as...

A Brief History of This Ambitious Project

Sensing the tech trend, Ubuntu tried its hands on creating a Linux-based mobile operating system. The first announcement came a decade back and six...

Atmanirbhar Apps by Mitron Launched to Promote Indian Apps

From the company that brought you Mitron, a TikTok-like video app, comes a new app ‘Atmanirbhar Apps’ that aims to promote apps made in...

How to Play PUBG Mobile in Restricted Regions

PUBG Mobile is one of the best battle royale games and has a community all over the world. Its Classic Deathmatch is pretty popular...

In its latest move, Russia has become the first country to approve a COVID-19 vaccine, and the same was announced by President Vladimir Putin on Tuesday, a Reuter report said. The vaccine has been developed by Moscow’s Gamaleya Institue and subjected to two months of human testing before getting the green light.

It will be named “Sputnik,” which was also the name of Russia’s first orbital satellite, according to Kirill Dmitriev, who heads the Russian investment fund that provided financial aid to the vaccine development.

After the vaccine enters mass production, it will be used to inoculate people, starting with the Russian population, followed by some other parts of the world. Putin has assured that vaccine boosts immunity, and it’s even used to inoculate one of his daughters.

I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the needed checks.”

However, Russia’s fast-paced approval has raised concerns across the globe as many fear the hastiness to release a COVID-19 vaccine might bring something ineffective or not adequately tested. Speaking of which Russia’s vaccine is yet to enter mass human trials (Phase-III) where it will be tested on thousands of humans to study the effects in further detail.

As far as initial testing is concerned, the Gamaleya vaccine has been given to a rather small subset of people, including the scientists who created it, 50 Russian military members, and some volunteers.

Moreover, the vaccine is still considered in Phase-I by the World Health Organisation (WHO). While around 100 vaccines are being developed globally, according to WHO data, at least four of them are under final Phase III human trials.

Its spokesman Christian Lindmeier said that a vaccine should go into various trials before its licensed for rollout, and there is a big difference “between finding or having a clue of maybe having a vaccine that works, and having gone through all the stages,” he added.

Source link

- Advertisement -

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Amazon sale: Up to Rs 41,400 discount on gaming laptops from Asus, Acer, MSI, Lenovo and others

If you are planning to buy a gaming laptop, then it may be a good idea to check out the deals on Amazon as...

A Brief History of This Ambitious Project

Sensing the tech trend, Ubuntu tried its hands on creating a Linux-based mobile operating system. The first announcement came a decade back and six...

Atmanirbhar Apps by Mitron Launched to Promote Indian Apps

From the company that brought you Mitron, a TikTok-like video app, comes a new app ‘Atmanirbhar Apps’ that aims to promote apps made in...

How to Play PUBG Mobile in Restricted Regions

PUBG Mobile is one of the best battle royale games and has a community all over the world. Its Classic Deathmatch is pretty popular...

Reliance Jio Becomes First Telco to Cross 400 Million Subscribers in India

At its latest earnings call on Saturday, India’s largest wireless carrier, Reliance Jio, announced that its subscriber base has now crossed 400 million (40...